The latest update is out from Cardiff Oncology, Inc. (CRDF).
Cardiff Oncology, Inc. has made a significant announcement about presenting five abstracts at the prestigious AACR event in San Diego, showcasing their latest cancer research findings. While this news is of substantial interest to investors, it is noted that the details released are not for official filing purposes under certain sections of the Securities and Exchange Act but serve as an insight into the company’s future directions and expectations.
For a thorough assessment of CRDF stock, go to TipRanks’ Stock Analysis page.
